Latest filing published 12 Feb 2019 for Gossamer Bio, Inc..
Insider track record
Thomas O. Daniel: trading record in brief
Thomas O. Daniel is a declared insider at 4 companies; the most frequent names are Celgene Corp /DE/, Larimar Therapeutics, Inc. and Dianthus Therapeutics, Inc. /DE/. In total, 59 filings cover trades dated from 14 April 2012 to 12 February 2019.
The open-market record consists of 8 sales worth €25.7M, with no purchase. Outside the open market, there are 12 share grants and 37 option exercises.
On 12 February 2019 came the latest disclosure, a transaction in Gossamer Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas O. Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 38,095 sharesCommon StockSEC:0001209191-19-009449:0
- 24,527 sharesCommon StockSEC:0000899243-18-018338:0
- 8,687 shares@ US$5.1846.8% of flowCommon StockSEC:0000899243-18-000596:0
- 10,765 shares@ US$4.1853.2% of flowCommon StockSEC:0000899243-17-004099:0
- 7,500 shares0Common StockSEC:0001209191-15-086106:0
- 3,913 shares@ US$112.17Common StockSEC:0001209191-15-086106:1
- 17,244 shares@ US$36.96Common StockSEC:0001209191-15-065588:0
- 8,334 shares@ US$29.75Common StockSEC:0001209191-15-065588:1
- 25,578 shares@ US$130.82Common StockSEC:0001209191-15-065588:2
- 1,720 shares@ US$28.94Common StockSEC:0001209191-15-062824:0
- 13,000 shares@ US$29.75Common StockSEC:0001209191-15-062824:1
- 15,000 shares@ US$29.75Common StockSEC:0001209191-15-062824:2
- 29,720 shares@ US$133.96Common StockSEC:0001209191-15-062824:3
- 2,292 shares@ US$28.50Common StockSEC:0001209191-15-062824:4
- 1,506 shares@ US$36.96Common StockSEC:0001209191-15-062824:5
- 1,720 shares@ US$25.77Common StockSEC:0001209191-15-062824:6
- 1,128 shares@ US$30.74Common StockSEC:0001209191-15-062824:7
- 25,000 shares@ US$29.75Common StockSEC:0001209191-15-060908:0
- 5,156 shares@ US$25.77Common StockSEC:0001209191-15-060908:1
- 30,156 shares@ US$120.78Common StockSEC:0001209191-15-060908:2
- 11,200 shares0Common StockSEC:0001209191-15-038603:0
- 5,844 shares@ US$108.06Common StockSEC:0001209191-15-038603:1
- 8,334 shares0Common StockSEC:0001209191-15-021258:0
- 4,348 shares@ US$121.53Common StockSEC:0001209191-15-021258:1
- 15,559 shares0Common StockSEC:0001209191-15-011612:0
25 of 59 declarations